• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fredun Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5269.0
  • ISIN : INE194R01017
912.90 -37 (-3.84%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    898.90

  • Today’s High

    943.90

  • Open

    940.00

  • Perv Close

    949.40

  • 52W Low

    635.00

  • 52W High

    984.00

Key Indicators

  • P/E(TTM)

    20.71

  • Mar.Cap (₹Cr.)

    431.04

  • Div & Yield %

    0.08

  • Book Value(₹)

    299.47

  • Debt-Equity Ratio

    -3.84

  • AGM Date

    23-Jul-2025

  • EPS

    44.07

  • P/E Ratio

    20.71

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    431.04

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.72

  • BV (₹)

    299.50

  • Sales( ₹ in Cr.)

    451.71

  • NP (in Cr.)

    20.81

  • NP Var(%)

    33.0

  • Div%

    7.0

  • CPS (₹)

    53.50

  • EPS (₹)

    44.10

  • Traded Value (₹ in Lakhs)

    431.04

  • 52 Week High

    984.00

  • 52 Week Low

    635.00

  • Price BSE

    913.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    431.04

  • P/C Ratio

    17.10

  • P/E Ratio

    20.70

  • Price Vs.BV

    44.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 348.16 274.68 224.46 133.89 112.77 97.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 348.16 274.68 224.46 133.89 112.77 97.02
Other Income 0.92 1.82 1.63 1.40 0.52 0.38
Stock Adjustments 22.44 37.72 0.01 -1.17 5.04 6.08
Total Income 371.52 314.22 226.10 134.12 118.33 103.48
EXPENDITURE :            
Raw Materials 282.42 245.57 176.45 100.60 86.12 65.96
Power and Fuel Cost 4.03 3.17 3.68 3.32 3.21 3.10
Employee Cost 12.50 11.54 10.66 8.66 8.95 8.04
Other Manufacturing Expenses 11.68 8.08 6.59 3.87 4.41 3.03
Selling and Administration Expenses 20.77 14.55 12.76 7.80 6.43 9.83
Miscellaneous Expenses 1.22 1.71 0.46 0.28 0.37 2.90
Employee Benefit Expenses 12.50 11.54 10.66 8.66 8.95 8.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 332.61 284.62 210.60 124.54 109.48 92.87
Operating Profit 38.90 29.60 15.50 9.58 8.85 10.62
Interest 13.65 9.28 4.74 4.37 4.48 3.13
Gross Profit 25.25 20.32 10.76 5.21 4.37 7.49
Depreciation 3.80 2.81 2.16 2.00 1.88 1.33
Profit Before Tax 21.45 17.51 8.60 3.21 2.49 6.16
Current Tax 5.54 4.29 2.21 0.76 0.44 1.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.29 2.41 0.05 0.44 0.15 -0.02
Reported Net Profit 15.62 10.81 6.34 2.01 1.90 4.46
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 15.62 10.81 6.34 2.01 1.90 4.46
Adjustment below Net Profit -0.07 0.05 0.02 0.00 8.27 0.00
P & L Balance brought forward 28.55 18.00 11.93 10.18 0.00 3.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.33 0.31 0.28 0.27 0.00 0.31
P & L Balance carried down 43.77 28.55 18.00 11.93 10.18 7.84
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 7.00 7.00 7.00 7.00 6.60 6.50
Dividend Per Share(Rs) 0.70 0.70 0.70 0.70 0.66 0.65
Earnings Per Share-Unit Curr 33.25 23.84 14.29 5.05 4.77 11.18
Earnings Per Share(Adj)-Unit Curr 33.25 23.84 14.29 5.05 4.77 11.18
Book Value 255.15 194.27 153.07 107.96 103.57 97.73
Book Value(Adj)-Unit Curr 255.15 194.27 153.07 107.96 103.57 97.73

Shareholding Pattern

  • Promoter Group

    48.93%

  • Public Share Holding

    51.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,310,385 48.93 2,310,385 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,310,385 48.93 2,310,385 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 75,000 1.59 75,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 75,000 1.59 75,000 1
2] Non Institution
Bodies Corporate 37,599 0.80 23,499 32
Clearing Members 65 0.00 65 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 86,904 1.84 86,904 172
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 92,018 1.95 92,018 192
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 558,981 11.84 558,981 8
Individuals holding nominal share capital up to Rs. 1 lakh 1,542,927 32.68 1,472,757 7,486
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,336,277 49.48 2,249,207 7,902
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,721,662 100.00 4,634,592 7,906

Company Background

Fredun Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Fredun Pharmaceuticals Ltd
  • BSE Code : 5269.0
  • ISIN : INE194R01017

  • Incorporation Year

    1987

  • Registered Office

    26 Manoj Industrial Premises
    G D Ambedkar Marg Wadala, Mumbai,
    Maharashtra-400031

  • Telephone

    91-22-40318111

  • FAX

  • Chairman

    Daulat N Medhora

  • Managing Director

    Fredun N Medhora

  • Company Secretary

  • Auditor

    R.H. Nisar & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Fredun Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fredun Pharma 912.90 349.07 348.16 20.71 16.95
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10